24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years

NCT00976937 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

319

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Lixisenatide (AVE0010)
DRUG: Lixisenatide Placebo
DEVICE: Pen auto-injector
DRUG: Sitagliptin
DRUG: Sitagliptin Placebo
DRUG: Metformin

Sponsor

Sanofi